triphosphoric acid has been researched along with HIV-Associated Lipodystrophy Syndrome in 1 studies
triphosphoric acid: used as water softener, peptizing agent, emulsifier & dispersing agent; ingredient of cleansers; meat preservative; RN given refers to parent cpd; structure
HIV-Associated Lipodystrophy Syndrome: Defective metabolism leading to fat maldistribution in patients infected with HIV. The etiology appears to be multifactorial and probably involves some combination of infection-induced alterations in metabolism, direct effects of antiretroviral therapy, and patient-related factors.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Domingo, P | 1 |
| Cabeza, MC | 1 |
| Pruvost, A | 1 |
| Salazar, J | 1 |
| Gutierrez, Mdel M | 1 |
| Mateo, MG | 1 |
| Domingo, JC | 1 |
| Fernandez, I | 1 |
| Villarroya, F | 1 |
| Muñoz, J | 1 |
| Vidal, F | 1 |
| Baiget, M | 1 |
1 other study available for triphosphoric acid and HIV-Associated Lipodystrophy Syndrome
| Article | Year |
|---|---|
Relationship between HIV/Highly active antiretroviral therapy (HAART)-associated lipodystrophy syndrome and stavudine-triphosphate intracellular levels in patients with stavudine-based antiretroviral regimens.
Topics: Adult; Anthropometry; Antiretroviral Therapy, Highly Active; Cross-Sectional Studies; Female; HIV-As | 2010 |